ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 200692 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 200692; 2) Community: the network communities that were significantly associated with the response to NSC 200692; 3) Molecule: the relationships between components within communities and NSC 200692; 4) MDR: the compounds that were significantly associated with the NSC 200692.

NSC Compound Enrichment Correlation
NSC 670786 Null 0.000573863872925597 -0.47182223
NSC 673791 Null 0.000573863872925597 -0.23923681
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.000573863872925597 0.62133085
NSC 335753 HELIANGOLIDE 0.000610795106687072 -0.40923701
NSC 626880 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-hydroxy- phenyl)methylene]-, hydrochloride 0.000610795106687072 -0.37864352
NSC 666160 Bis[1-(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta 1,3-dien-1-thiolato-N',N3,S]nitrato-bismuth(III) 0.000610795106687072 -0.28885231
NSC 693639 Ethanone, 1-(2-pyrimidinyl)-, (2-benzoxazolyl)hydrazone 0.000610795106687072 -0.35475766
NSC 647763 Jasplakinolide epoxide C 0.000864214137711354 -0.065298477
NSC 98904 Thiazolo[3,2-f]phenanthridinium, 3-phenyl- perchlorate 0.000864214137711354 0.0057522947
NSC 664874 Null 0.000967118311825479 -0.35475109
Total:83  Current:3    [First] [Prev] [Next] [Last]